Olympus and Ziosoft Launch AI Surgical Planning Tool
Olympus Corporation has announced the launch of its first AI-powered clinical decision tool in partnership with Ziosoft, focusing on liver, lung, and kidney procedures.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Olympus Corporation has announced the launch of its first AI-powered clinical decision tool in partnership with Ziosoft, focusing on liver, lung, and kidney procedures.
Shiru and GreenLab have announced a strategic partnership to commercialize novel food proteins using a corn-based expression system, enhancing sustainable protein production.
Turacoz Group presented its AI-driven living systematic reviews at the World EPA 2025 Conference, highlighting advancements in evidence synthesis and healthcare decision-making.
Pramana and ARUP Laboratories have partnered to digitize pathology slides and develop AI algorithms for hematopathology, enhancing diagnostic precision and efficiency.
Caristo Diagnostics has received FDA 510(k) clearance for its AI-powered CaRi-Plaque technology, designed to aid in the diagnosis of coronary artery disease by analyzing coronary plaque.
Body Vision Medical has received regulatory approval from the Therapeutic Goods Administration for its LungVision imaging system in Australia, enhancing lung cancer diagnosis capabilities.
Reclaim Health has integrated its AI-powered healthcare financial management platform with WEX's benefits administration solution, aiming to improve decision-making for employers and employees.
moveUP.care has announced its acquisition of Deep Structure.ai, a US-based digital health company specializing in AI-driven orthopedic care, to strengthen its capabilities and expand its presence in the US.
Tethis and Sheba Medical Center have announced a research collaboration to advance AI-powered liquid biopsy technology for rectal cancer, focusing on circulating tumor cells and ctDNA.
RamSoft has partnered with CARPL.ai to integrate over 150 AI applications into its PowerServer and OmegaAI platforms, enhancing radiology workflows.
ARUP Laboratories has expanded its AI-augmented screening tool to include wet-mount slides, enhancing the detection of gastrointestinal parasites.
Paradigm Health has appointed Dr. David Shulkin to its advisory board to enhance AI-driven cancer clinical trials in rural America, as announced in a press release.
Modern Sports Medicine & Wellness has announced a partnership with NeuralCure AI to integrate AI-powered decision support into non-surgical orthobiologic treatments, enhancing patient care and telehealth services.
Pusan National University researchers have developed the Hypergraph Interaction Transformer, an AI model that accelerates the identification of therapeutic gene targets using hypergraphs.
League has announced a new AI-powered suite at its annual conference, featuring AI Health Actions and a Benefits AI Guide to improve healthcare engagement.
Sirona Medical has announced that Dr. Curtis Langlotz, a leading figure in AI and medical imaging, will join its board of directors.
A recent study published in AI in Precision Oncology demonstrates the ability of large language models to accurately extract PD-L1 biomarker details from electronic health records.
The Roddenberry Foundation has awarded iCardio.ai a $1 million prize for its AI platform that enhances heart disease diagnosis and prevention.
Suvoda has launched Sofia, an AI assistant designed to streamline clinical trial management by simplifying data access and analysis for drug supply managers.
A recent survey by Omega Healthcare reveals that 85% of healthcare executives believe AI will enhance revenue cycle management operations over the next five years.